0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA | 
Research Letter | 
Andrew Fenelon, PhD; Li-Hui Chen, PhD; Susan P. Baker, MPH
JAMA. 2016;315(6):609-611. doi:10.1001/jama.2015.15564.

JAMA | 
News From the Centers for Disease Control and Prevention | 
JAMA. 2016;315(6):550. doi:10.1001/jama.2016.0085.

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Jonathan Douxfils, PharmD, PhD; Hélène Haguet, MBS; François Mullier, PharmD, PhD; et al.
JAMA Oncol. Published online February 04, 2016. doi:10.1001/jamaoncol.2015.5932
Includes: Supplemental Content

JAMA Oncology | 
Review |  ONLINE FIRST
Gary W. Jean, PharmD; Rene M. Mani, PharmD; Aliza Jaffry, PharmD; et al.
JAMA Oncol. Published online February 04, 2016. doi:10.1001/jamaoncol.2015.5927

JAMA Oncology | 
Invited Commentary |  ONLINE FIRST
Steven M. Offer, PhD; Robert B. Diasio, MD
JAMA Oncol. Published online January 21, 2016. doi:10.1001/jamaoncol.2015.5463

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Valérie Boige, MD, PhD; Marc Vincent, PhD; Philippe Alexandre, MS; et al.
JAMA Oncol. Published online January 21, 2016. doi:10.1001/jamaoncol.2015.5392
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Nicholas D. James, PhD, FRCR, FRCP; Sarah J. Pirrie, MSc; Ann M. Pope, PhD; et al.
JAMA Oncol. Published online January 21, 2016. doi:10.1001/jamaoncol.2015.5570
Includes: Supplemental Content

JAMA Neurology | 
Viewpoint | 
Axel Montagne, PhD; Arthur W. Toga, PhD; Berislav V. Zlokovic, MD, PhD
JAMA Neurol. 2016;73(1):13-14. doi:10.1001/jamaneurol.2015.2960.

JAMA Oncology | 
Editorial | 
Gérard Milano, PhD; Emmanuel Chamorey, PharmD, PhD; Jean-Marc Ferrero, MD, PhD
JAMA Oncol. 2016;2(1):21-22. doi:10.1001/jamaoncol.2015.3866.

JAMA Oncology | 
Original Investigation | 
Chau Dang, MD; Hao Guo, MS; Julie Najita, PhD; et al.
JAMA Oncol. 2016;2(1):29-36. doi:10.1001/jamaoncol.2015.3709.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
Research Letter  | 
Major Causes of Injury Death and the Life Expectancy Gap Between the United States and Other High-Income Countries
Andrew Fenelon, PhD; Li-Hui Chen, PhD; Susan P. Baker, MPH
JAMA
News From the Centers for Disease Control and Prevention  | 
Opioid Overdoses Continue to Climb

JAMA Oncology
Original Investigation  | 
Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival A Systematic Review and Meta-analysis
Jonathan Douxfils, PharmD, PhD; Hélène Haguet, MBS; François Mullier, PharmD, PhD; et al.
JAMA Oncology
Review  | 
Toxic Effects of Sorafenib in Patients With Differentiated Thyroid Carcinoma Compared With Other Cancers
Gary W. Jean, PharmD; Rene M. Mani, PharmD; Aliza Jaffry, PharmD; et al.